CLU and Familial prostate cancer: This observation was not confirmed by our (Bettuzzi et al, 2000; Scaltriti et al, 2004; Caporali et al, 2004) and other publications (Stuart et al, 2004), demonstrating that clusterin is indeed more frequently downregulated in prostate cancer.